Microbio Co., Ltd. receives a Brazil patent
on the new drug MS-20 (CHEMO YOUNG).
Date of events
2022/04/15
To which item it meets
paragraph 53
Statement
1.Date of occurrence of the event:2022/04/15
2.Company name:Microbio Co., LTD.
3.Relationship to the Company (please enter "head office" or
"subsidiaries"):Head office
4.Reciprocal shareholding ratios:NA
5.Cause of occurrence:The Company has been informed by the patent agency that
the new drug: MS-20 has been granted a Brazil patent titled
"USE OF A FERMENTED SOY EXTRACT AND COMPOSITION"under patent number
BR1120130013699.
6.Countermeasures:NA
7.Any other matters that need to be specified:
(1)The new drug MS-20 has obtained patents from the U.S.,
the Republic of China, Japan, the People's Republic of China, the Hong Kong
Special Administrative Region, Europe, Korea, Indonesia, India, Canada,
Malaysia, Singapore and United Arab Emirates.
(2)This is an essential patent for the MS20 manufacturing, which protects
MS20 and prevents similar drugs into the market.
Attachments
Original Link
Original Document
Permalink
Disclaimer
Microbio Co. Ltd. published this content on 15 April 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 15 April 2022 09:09:08 UTC.
Microbio Co., Ltd. is a Taiwan-based company primarily engaged in the research, development, manufacture, distribution and wholesales of healthcare food products and pharmaceuticals. The Company provides fermentation products, including Tien Chun Bao (TCB) oral solutions; herbal products, including LeeHerb series products, as well as organic foods, including vegetables, fruits, nuts, pastry, seasonings, organic meals and others. In addition, it provides new medicines, including anticancer medicines, medicines for hepatitis, allergy, rheumatoid arthritis and others. The Company mainly distributes its products mainly within domestic market.
MICROBIO CO., LTD. 
